HSDT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.30%

Insider Buying (Last 12 Months): $93,346.86

Insider Selling (Last 12 Months): $0.00

Helius Medical Technologies Insider Trading History Chart

Helius Medical Technologies Share Price & Price History

^$9.49

▲ +0.39 (4.29%)

As of 09/29/2023 01:00 AM ET

Days: 30 | 90 | 365

This Stock Could Go Up 66% or More.

From Chaikin Analytics | Ad

Marc Chaikin built the system that isolated NVDA before it became the best-performing stock of 2023. Click here to get his latest buy. More here.

More here.

Helius Medical Technologies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2023	Dane C. Andreeff	CEO	Buy	5,000	$7.64	$38,200.00	11,420
8/28/2023	Dane C. Andreeff	CEO	Buy	5,078	$6.37	$32,346.86	8,774
12/16/2022	Dane C. Andreeff	CEO	Buy	1,600	$12.50	$20,000.00	6,650
11/22/2022	Dane C. Andreeff	CEO	Buy	200	$14.00	$2,800.00	4,371
9/12/2022	Dane C. Andreeff	CEO	Buy	177	$27.00	$4,779.00	2,896
8/24/2022	Dane C. Andreeff	CEO	Buy	504	$32.50	$16,380.00	1,999
12/17/2021	Dane C. Andreeff	CEO	Buy	102	$262.50	$26,775.00
12/17/2021	Jeffrey S. Mathiesen	CFO	Buy	60	$265.50	$15,930.00
11/12/2021	Dane C. Andreeff	CEO	Buy	750	$400.00	$300,000.00

DOD Consultant's big 2024 prediction looks to be coming true

From Altimetry | Ad

Earlier this year, a Department of Defense (DOD) consultant went public with a big prediction…About how a surprising 2024 event would dramatically affect you and your money. The most recent figures (published June 9th 2023) indicate he’s very likely to be right. Get the facts—learn how to prepare. Full analysis available free of charge here…

Full analysis available free of charge here…

SEC Filings (Institutional Ownership Changes) for Helius Medical Technologies (NASDAQ:HSDT)

Institutional Buying and Selling by Quarter

Helius Medical Technologies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/11/2023	Renaissance Technologies LLC	227,600	$44K	0.0%	+2,047.2%	0.807%
2/13/2023	Renaissance Technologies LLC	159,600	$49K	0.0%	-47.6%	0.566%
11/15/2022	BlackRock Inc.	255,381	$71K	0.0%	+8,297.9%	0.906%
11/14/2022	Renaissance Technologies LLC	304,564	$84K	0.0%	+556.8%	1.080%
7/20/2022	Delta Investment Management LLC	26,784	$32K	0.0%	-31.8%	0.705%
5/13/2022	Vanguard Group Inc.	54,692	$0.18M	0.0%	-31.3%	1.439%
2/15/2022	Kepos Capital LP	100,304	$0.52M	0.0%	+296.4%	4.190%
2/14/2022	Altium Capital Management LP	48,862	$0.25M	0.1%	N/A	2.041%
2/11/2022	Rovida Advisors Inc.	26,934	$0.14M	0.0%	-27.1%	1.125%
2/10/2022	AIGH Capital Management LLC	250,000	$1.30M	0.4%	N/A	10.443%
2/3/2022	ACT Capital Management LLC	35,263	$0.18M	0.1%	-50.1%	1.473%
11/16/2021	ACT Capital L.L.C.	70,616	$1.02M	0.5%	+19.3%	2.950%
11/12/2021	Renaissance Technologies LLC	37,270	$0.54M	0.0%	-9.0%	1.604%
11/12/2021	Delta Investment Management LLC	37,184	$0.54M	0.2%	N/A	1.601%
8/17/2021	Worth Venture Partners LLC	17,915	$0.30M	0.1%	-24.7%	0.771%
8/13/2021	Renaissance Technologies LLC	40,970	$0.70M	0.0%	-8.1%	1.764%
8/13/2021	Geode Capital Management LLC	16,390	$0.28M	0.0%	+57.2%	0.706%
8/13/2021	Vanguard Group Inc.	78,898	$1.34M	0.0%	+186.4%	3.396%
8/10/2021	Isthmus Partners LLC	5,595	$95K	0.0%	N/A	0.241%
5/19/2021	Worth Venture Partners LLC	23,785	$0.43M	0.2%	N/A	1.027%
5/14/2021	Rovida Advisors Inc.	36,934	$0.65M	0.0%	-97.1%	1.594%
5/13/2021	Renaissance Technologies LLC	44,570	$0.80M	0.0%	-96.1%	1.924%
5/13/2021	Kepos Capital LP	25,304	$0.46M	0.0%	N/A	1.092%
5/12/2021	Geode Capital Management LLC	10,426	$0.19M	0.0%	N/A	0.450%
5/12/2021	UBS Group AG	2,305	$41K	0.0%	+1,180.6%	0.099%
5/7/2021	BlackRock Inc.	3,041	$55K	0.0%	-97.1%	0.131%
3/25/2021	Rollins Financial	100,000	$38K	0.0%	N/A	4.327%
2/16/2021	Isthmus Partners LLC	195,829	$74K	0.0%	-4.4%	8.474%
2/10/2021	Renaissance Technologies LLC	1,139,288	$0.43M	0.0%	+9.2%	76.771%
2/5/2021	BlackRock Inc.	106,546	$41K	0.0%	+2.2%	7.103%
7/30/2020	Camelot Portfolios LLC	90,000	$38K	0.0%	N/A	0.216%
5/15/2020	Sabby Management LLC	746,316	$0.25M	0.1%	N/A	2.881%
2/13/2020	Renaissance Technologies LLC	166,505	$0.16M	0.0%	+1,132.9%	0.549%
2/4/2020	Virtu Financial LLC	85,388	$83K	0.0%	N/A	0.282%
11/27/2019	Millennium Management LLC	207,895	$0.34M	0.0%	+627.9%	0.803%
8/14/2019	Morgan Stanley	14,072	$31K	0.0%	+302.7%	0.054%
8/14/2019	Paloma Partners Management Co	80,400	$0.18M	0.0%	N/A	0.310%
8/14/2019	Vanguard Group Inc.	684,257	$1.51M	0.0%	-16.5%	2.926%
8/14/2019	A.R.T. Advisors LLC	15,748	$35K	0.0%	N/A	0.067%
8/14/2019	Weiss Asset Management LP	25,568	$56K	0.0%	N/A	0.109%
8/13/2019	BlackRock Inc.	160,590	$0.35M	0.0%	-82.5%	0.687%
8/13/2019	Parametric Portfolio Associates LLC	23,986	$53K	0.0%	-35.2%	0.103%
8/13/2019	Northern Trust Corp	193,414	$0.43M	0.0%	-6.4%	0.827%
8/10/2019	Isthmus Partners LLC	205,829	$0.45M	0.1%	-48.0%	0.880%
8/9/2019	Bank of Montreal Can	20,701	$45K	0.0%	+6,777.4%	0.089%
4/1/2019	Deutsche Bank AG	32,448	$0.30M	0.0%	-18.9%	0.139%
2/14/2019	Bank of America Corp DE	14,279	$0.13M	0.0%	+61.6%	0.056%
2/14/2019	Polar Capital LLP	400,000	$3.66M	0.0%	N/A	1.569%
2/13/2019	Geode Capital Management LLC	184,087	$1.69M	0.0%	+47.9%	0.722%
2/12/2019	Northern Trust Corp	204,962	$1.88M	0.0%	+26.4%	0.804%
2/11/2019	Scotia Capital Inc.	16,855	$0.15M	0.0%	N/A	0.066%
2/11/2019	Bank of New York Mellon Corp	47,827	$0.44M	0.0%	+14.5%	0.188%
2/8/2019	BlackRock Inc.	899,400	$8.24M	0.0%	+12.0%	3.527%
2/4/2019	Isthmus Partners LLC	205,829	$1.89M	0.6%	-5.9%	0.807%
1/31/2019	Rhumbline Advisers	20,263	$0.19M	0.0%	+54.8%	0.079%
1/30/2019	Trust Co. of Vermont	3,000	$27K	0.0%	N/A	0.012%
1/25/2019	Pembroke Management LTD	795,649	$9.88M	1.3%	-5.7%	3.120%
1/1/2019	TIAA CREF Investment Management LLC	20,377	$0.20M	0.0%	-18.5%	0.080%
12/13/2018	Vanguard Group Inc	857,423	$8.39M	0.0%	-0.6%	3.362%
11/9/2018	CIBC World Markets Inc.	10,367	$0.10M	0.0%	N/A	0.044%
11/9/2018	BlackRock Inc.	803,164	$7.86M	0.0%	+9.4%	3.435%
11/7/2018	JPMorgan Chase & Co.	15,146	$0.15M	0.0%	-58.1%	0.065%
9/18/2018	Northern Trust Corp	36,145	$0.34M	0.0%	N/A	0.155%
8/9/2018	BlackRock Inc.	734,407	$6.99M	0.0%	N/A	3.141%
8/8/2018	Schwab Charles Investment Management Inc.	30,500	$0.29M	0.0%	N/A	0.130%
8/6/2018	Bank of New York Mellon Corp	41,755	$0.40M	0.0%	N/A	0.179%
8/6/2018	Rhumbline Advisers	13,825	$0.13M	0.0%	N/A	0.059%
8/2/2018	Isthmus Partners LLC	236,934	$2.26M	0.6%	+67.8%	1.013%
7/27/2018	Pembroke Management LTD	843,499	$10.27M	1.0%	N/A	3.608%
7/25/2018	Pier 88 Investment Partners LLC	19,430	$0.19M	0.1%	N/A	0.083%

Data available starting January 2016

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

Today's Range

Now: $9.49

$8.99

$9.50

50 Day Range

MA: $8.68

$5.83

$10.97

52 Week Range

Now: $9.49

$5.69

$20.95

Volume

15,150 shs

Average Volume

1,210,950 shs

Market Capitalization

$5.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of Helius Medical Technologies?: Helius Medical Technologies' top insider shareholders include:
Dane Andreeff (CEO)
Jeffrey S Mathiesen (CFO)
Learn More about top insider investors at Helius Medical Technologies.